NextCell Pharma AB

NextCell Pharma AB is at the forefront of biotechnology research, dedicated to developing advanced therapy medicinal products, particularly in the realm of autoimmune diseases and transplantation. With a strong foundation built upon expertise in umbilical cord stem cells and a focus on innovative solutions, NextCell Pharma AB is committed to advancing healthcare through groundbreaking research and development.

Located at Hälsovägen 7, Karolinska Institutet Science Park, Novum 8D, Huddinge, 14157, SE, NextCell Pharma AB operates with a clear vision: to provide next-generation cell therapies that address critical medical needs. The company's primary product, ProTrans, has already entered clinical trials, marking a significant milestone in its mission to improve patient outcomes and transform the treatment landscape.

NextCell Pharma AB is poised for continued growth and success in the biotechnology sector. We invite the manager of NextCell Pharma AB to create a customized and exclusive company showcase and product listing on our platform, to further highlight their innovative contributions and commercial potential.